Spencer Raab, M.D.; Miriam Dahlke, M.D.
This content is PDF only. Please click on the PDF icon to access.
The treatment of multiple myeloma with agents such as radioactive phosphorus, urethane, corticosteroids, etc., has been most discouraging. Recently, the use of cyclophosphamide has resulted in some prolongation of survival in this disease. In addition, L-phenylalanine mustard (melphalan) has also been shown to be associated with an initial improvement in some patients. This study was undertaken to assess the value of continuous mainentance therapy with this drug for the life of the patient.
All patients in whom the diagnosis of multiple myeloma was made in the past 12 months at the Philadelphia General Hospital and on the wards at the
Learn more about subscription options.
Register Now for a free account.
Raab S, Dahlke M. The Treatment of Multiple Myeloma and Macroglobulinemia of Waldenstrom with the Continuous Administration of L-Phenylalanine Mustard.. Ann Intern Med. 1965;63:913. doi: 10.7326/0003-4819-63-5-913_1
Download citation file:
Published: Ann Intern Med. 1965;63(5):913.
Hematology/Oncology, Multiple Myeloma.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only